Metropolitan Life Insurance Company (MetLife)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,763
Closed -$838K 2387
2021
Q4
$838K Sell
10,763
-81
-0.7% -$6.3K 0.01% 1096
2021
Q3
$1.04M Sell
10,844
-359
-3% -$34.3K 0.02% 919
2021
Q2
$1.39M Buy
11,203
+1,419
+15% +$176K 0.02% 759
2021
Q1
$1.29M Sell
9,784
-408
-4% -$53.8K 0.02% 776
2020
Q4
$1.35M Sell
10,192
-203
-2% -$26.9K 0.02% 685
2020
Q3
$1.06M Sell
10,395
-265
-2% -$27K 0.02% 713
2020
Q2
$927K Buy
10,660
+852
+9% +$74.1K 0.02% 778
2020
Q1
$569K Sell
9,808
-309
-3% -$17.9K 0.01% 978
2019
Q4
$936K Buy
10,117
+701
+7% +$64.8K 0.01% 929
2019
Q3
$851K Buy
9,416
+595
+7% +$53.8K 0.01% 951
2019
Q2
$1.04M Sell
8,821
-204
-2% -$24.1K 0.02% 870
2019
Q1
$782K Sell
9,025
-189
-2% -$16.4K 0.01% 1022
2018
Q4
$581K Sell
9,214
-29
-0.3% -$1.83K 0.01% 1099
2018
Q3
$729K Sell
9,243
-184
-2% -$14.5K 0.01% 1103
2018
Q2
$564K Sell
9,427
-27,700
-75% -$1.66M 0.01% 1233
2018
Q1
$1.5M Buy
37,127
+440
+1% +$17.7K 0.02% 703
2017
Q4
$1.93M Sell
36,687
-41,490
-53% -$2.18M 0.03% 570
2017
Q3
$3.68M Buy
78,177
+4,641
+6% +$219K 0.02% 735
2017
Q2
$2.6M Buy
73,536
+743
+1% +$26.3K 0.02% 864
2017
Q1
$1.72M Sell
72,793
-1,324
-2% -$31.3K 0.01% 1003
2016
Q4
$990K Hold
74,117
0.01% 1299
2016
Q3
$1.38M Buy
74,117
+5,782
+8% +$107K 0.01% 1112
2016
Q2
$837K Sell
68,335
-10,838
-14% -$133K 0.01% 1359
2016
Q1
$534K Buy
79,173
+13,892
+21% +$93.7K ﹤0.01% 1547
2015
Q4
$603K Hold
65,281
﹤0.01% 1506
2015
Q3
$1.17M Buy
65,281
+505
+0.8% +$9.08K 0.01% 1115
2015
Q2
$1.93M Sell
64,776
-2,993
-4% -$89K 0.01% 981
2015
Q1
$1.49M Buy
67,769
+2,862
+4% +$63K 0.01% 1002
2014
Q4
$1.78M Buy
64,907
+2,153
+3% +$59.1K 0.01% 1016
2014
Q3
$1.22M Sell
62,754
-4,940
-7% -$95.7K 0.01% 1168
2014
Q2
$1.15M Buy
67,694
+11,947
+21% +$203K 0.01% 1264
2014
Q1
$790K Sell
55,747
-3,067
-5% -$43.5K 0.01% 1512
2013
Q4
$688K Hold
58,814
﹤0.01% 1587
2013
Q3
$695K Buy
58,814
+7,174
+14% +$84.8K 0.01% 1531
2013
Q2
$718K Buy
+51,640
New +$718K 0.01% 1454